Riskpilot← Back to searchSign inGet full accessUnicornis Medica AB
ABActiveOrg 5569622136Bragevägen 5Business and other management consultancy activities · NACE 7020Est. 20140 employees
Revenue 2024
SEK 1M
-56% vs 2023
EBITDA margin
10.8%
-85% vs 2023
Equity ratio
72.4%
Financial strength
Net profit 2024
SEK 173K
-69% vs 2023
| Revenue | SEK 1M | -56% |
| EBITDA | SEK 110K | -85% |
| Net profit | SEK 173K | -69% |
| Total assets | SEK 2,4M | -10% |
| Equity | SEK 1,8M | -1% |
| Employees | 0 | — |
Legal name
Unicornis Medica AB
Org number
5569622136
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
17 februari 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinska konsultationer, läkarvård hos olika vårdgivare, hålla föreläsningar och utbildningar inom hälso- och sjukvård, bedriva publicistisk och litterär verksamhet, förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Bragevägen 5
Email
jorgen.nordenstrom@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 550 | 612 | 68 | 2 321 | 1 020 |
| Staff expenses | — | — | −6 | −2 | — |
| EBITDA | 239 | 218 | −164 | 730 | 110 |
| Depreciation & amort. | −0 | −0 | — | — | −0 |
| EBIT | 239 | 218 | −164 | 730 | 110 |
| Net financials | — | — | −122 | 145 | 44 |
| Profit before tax | 177 | 160 | 14 | 679 | 230 |
| Tax | −40 | −37 | −36 | −122 | −57 |
| Net profit | 137 | 123 | −22 | 557 | 173 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 324 | 2 239 | 1 740 | 2 695 | 2 426 |
| Equity | 1 691 | 1 632 | 1 422 | 1 783 | 1 757 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 103 | 21 | 31 | 429 | 263 |
| Total debt | 103 | 21 | 31 | 429 | 263 |
EBITDA margin
10.8%
This company
15.8%
Market median
-32% vs market
20202024
Equity ratio
72.4%
This company
38.2%
Market median
+90% vs market
20202024
Return on equity
9.8%
This company
18.4%
Market median
-47% vs market
20202024
Net profit margin
17.0%
This company
8.1%
Market median
+110% vs market
20202024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TD Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Unicornis Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tekin Deniz | Audit | 0 companies |
| Daisy Marianne Kaplan | Deputy Board Member | 0 companies |
| Johan Oscar Wilhelm Nordenström | Deputy Board Member | 0 companies |
| Jörgen Wilhelm Nordenström | Board of Directors | 0 companies |